Operative time greater than 120 minutes is associated with increased pulmonary and thromboembolic complications following revision total hip arthroplasty
Background The aim of this study was to determine the impact of operative time on the development of early postoperative complications in patients undergoing revision total hip arthroplasty (THA). Methods In this retrospective cohort study, data were collected through the American College of Surgeon...
Gespeichert in:
Veröffentlicht in: | European journal of orthopaedic surgery & traumatology 2020-12, Vol.30 (8), p.1393-1400 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
The aim of this study was to determine the impact of operative time on the development of early postoperative complications in patients undergoing revision total hip arthroplasty (THA).
Methods
In this retrospective cohort study, data were collected through the American College of Surgeons National Quality Improvement Program Database. All patients who underwent revision THA between 2007 and 2016 were identified and stratified into groups based on operative time|: 0–60 min, 61–120 min, 121–180 min, and > 180 min. The incidence of early postoperative adverse events with 30 days, including cardiac, pulmonary, renal, septic, thromboembolic, urinary tract, and wound complications, death, length of stay > 7 days, and unplanned return to the operating room were collected. The complications rates following revision THA were evaluated with univariate and multivariate analyses with significance set at
p
120 min of operative time had a significantly increased risk of the development of pulmonary (OR: 1.339; 95% CI: 1.08–1.661;
p
= 0.008) and thromboembolic complications (OR: 1.34; 95% CI: 1.053–1.707;
p
= 0.017) and also had an extended length of stay greater than 7 days (OR: 1.413; 95% CI: 1.295–1.541;
p
120 min) during revision THA is associated with increased risk of pulmonary and thromboembolic complications, and prolonged hospitalizations (greater than seven days). |
---|---|
ISSN: | 1633-8065 1432-1068 |
DOI: | 10.1007/s00590-020-02712-4 |